Discontinued — last reported Q3 '24

Current Liabilities

Finance Lease Liability, Current

This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLeverage
SignalLower is better
VolatilityModerate
First reportedQ3 2022
Last reportedQ3 2024

How to read this metric

Rising values indicate increased use of debt-like financing for capital expenditures, whereas falling values suggest the company is paying down its financed obligations.

Detailed definition

The current portion of obligations arising from leases that are effectively asset purchases, where the risks and rewards...

Peer comparison

This is often compared to short-term debt to understand the total mandatory cash outflows for financing activities.

Metric ID: finance_lease_liabilities_current

Historical Data

9 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q4 '25Q1 '26
Value$718.40M$719.00M$719.70M$0.00$0.00$0.00$0.00$0.00$720.00M
QoQ Change+0.1%+0.1%-100.0%
YoY Change-100.0%-100.0%-100.0%
Range$0.00$720.00M
CAGR+0.1%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Finance Lease Liability, Current at Other Companies

Frequently Asked Questions

What is Regeneron Pharmaceuticals's finance lease liability, current?
Regeneron Pharmaceuticals (REGN) reported finance lease liability, current of $720.00M in Q1 2026.
What does finance lease liability, current mean?
The portion of debt-like lease payments for equipment or property that must be paid within the next year.